Bio-Techne Shareholders Approve Acquisition By Merck KGaA, Darmstadt, Germany
TECH•Shareholders approve acquisition
Bio-Techne Corporation shareholders approved the acquisition by Merck KGaA, Darmstadt, Germany.
The deal is expected to close by late 2026 or early 2027, pending regulatory approvals.




